HSS Journal ®

, Volume 8, Issue 2, pp 175–183 | Cite as

Cardiac Arrest during Total Hip Arthroplasty in a Patient on an Angiotensin Receptor Antagonist

  • Susan M. Goodman
  • Daniel Krauser
  • C. Ronald Mackenzie
  • Stavros Memtsoudis
Rheumatology Corner/CME Article


Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor antagonists (ARA) are effective and well-tolerated first-line drugs in the therapy of hypertension and, therefore, are frequently encountered in the perioperative setting. Hemodynamic compensation for volume depletion seen in the perioperative period is normally mediated by the renin–angiotensin system, which is blocked by ACEI/ARA. These drugs may contribute to severe hypotension during anesthesia induction and may have contributed to the cardiac arrest seen in this patient. Additional factors such as increased intra-abdominal pressures and respiratory obstructive episodes leading to diminished venous return, as well diuretic use and the fasting state, common in the perioperative orthopedic patient, are likely to have contributed as well. Medication use may be an easily modifiable risk factor for severe hypotension and possible cardiac arrest in the perioperative setting.


cardiac arrest perioperative antihypertensive therapy Angiotensin converting enzyme inhibitors Bezold –Jarisch reflex intra-operative hypotension renin angiotensin system (RAS) 


  1. 1.
    Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, Lohr J. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol. 2008;5:1266–1273.CrossRefGoogle Scholar
  2. 2.
    Barreras A, Gurk-Turner C. Angiotensin II receptor blockers. Proc (Bayl Univ Med Cent). 2003;1:123–126.Google Scholar
  3. 3.
    Brabant SM, Bertrand M, Eyraud D, Darmon PL, Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg. 1999;6:1388–1392.Google Scholar
  4. 4.
    Brabant SM, Eyraud D, Bertrand M, Coriat P. Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists. Anesth Analg. 1999;4:887–888.Google Scholar
  5. 5.
    Butterworth J, Furberg CD. Improving cardiac outcomes after noncardiac surgery. Anesth Analg. 2003;3:613–615.CrossRefGoogle Scholar
  6. 6.
    Cittanova ML, Zubicki A, Savu C, Montalvan C, Nefaa N, Zaier K, Riou B, Coriat P. The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function. Anesth Analg. 2001;5:1111–1115.CrossRefGoogle Scholar
  7. 7.
    Colson P, Ryckwaert F, Coriat P. Renin angiotensin system antagonists and anesthesia. Anesth Analg. 1999;5:1143–1155.CrossRefGoogle Scholar
  8. 8.
    Comfere T, Sprung J, Kumar MM, Draper M, Wilson DP, Williams BA, Danielson DR, Liedl L, Warner DO. Angiotensin system inhibitors in a general surgical population. Anesth Analg. 2005;3:636–44, table of contents.CrossRefGoogle Scholar
  9. 9.
    Cozanitis DA. The importance of interrupting angiotensin converting enzyme inhibitor treatment before spinal anaesthesia--a controlled case report. Anaesthesiol Reanim. 2004;1:16–18.Google Scholar
  10. 10.
    Eyraud D, Mouren S, Teugels K, Bertrand M, Coriat P. Treating anesthesia-induced hypotension by angiotensin II in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg. 1998;2:259–263.Google Scholar
  11. 11.
    Hartmann B, Junger A, Klasen J, Benson M, Jost A, Banzhaf A, Hempelmann G. The incidence and risk factors for hypotension after spinal anesthesia induction: An analysis with automated data collection. Anesth Analg. 2002;6:1521–9, table of contents.Google Scholar
  12. 12.
    Kashihara K. Roles of arterial baroreceptor reflex during bezold-jarisch reflex. Curr Cardiol Rev. 2009;4:263–267.CrossRefGoogle Scholar
  13. 13.
    Kheterpal S, Khodaparast O, Shanks A, O’Reilly M, Tremper KK. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth. 2008;2:180–186.CrossRefGoogle Scholar
  14. 14.
    Larochelle P, Flack JM, Marbury TC, Sareli P, Krieger EM, Reeves RA. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. irbesartan multicenter investigators. Am J Cardiol. 1997;12:1613–1615.CrossRefGoogle Scholar
  15. 15.
    Liu SS, Della Valle AG, Besculides MC, Gaber LK, Memtsoudis SG. Trends in mortality, complications, and demographics for primary hip arthroplasty in the united states. Int Orthop. 2009;3:643–651.CrossRefGoogle Scholar
  16. 16.
    Memtsoudis SG, Della Valle AG, Besculides MC, Gaber L, Laskin R. Trends in demographics, comorbidity profiles, in-hospital complications and mortality associated with primary knee arthroplasty. J Arthroplasty. 2009;4:518–527.CrossRefGoogle Scholar
  17. 17.
    Moser M. Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists and calcium channel blocking agents: A review of potential benefits and possible adverse reactions. J Am Coll Cardiol. 1997;7:1414–1421.CrossRefGoogle Scholar
  18. 18.
    Railton CJ, Wolpin J, Lam-McCulloch J, Belo SE. Renin-angiotensin blockade is associated with increased mortality after vascular surgery. Can J Anaesth. 2010;8:736–744.Google Scholar
  19. 19.
    Wijeysundera DN, Beattie WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: A meta-analysis. Anesth Analg. 2003;3:634–641.CrossRefGoogle Scholar

Copyright information

© Hospital for Special Surgery 2011

Authors and Affiliations

  • Susan M. Goodman
    • 1
    • 2
  • Daniel Krauser
    • 1
    • 2
  • C. Ronald Mackenzie
    • 1
    • 2
  • Stavros Memtsoudis
    • 1
    • 2
  1. 1.Hospital for Special SurgeryNew YorkUSA
  2. 2.Weill Cornell Medical CollegeNew YorkUSA

Personalised recommendations